BioInvent International

BioInvent International (OMXS:BINV) is a research based biopharmaceutical company developing innovative antibody-based drugs for the treatment of cancer. The Company's competitive position is underpinned by n-CoDeRĀ®, a proprietary library of fully-human antibodies that allow the selection of high-affinity targets for drug discovery.

The Company is headquartered in Lund, Sweden.